JIM CRAMERColored by Coronavirus: Cramer's 'Mad Money' Recap (Friday 2/14/20)By Scott RuttFeb 14, 2020 8:32 PM EST
EARNINGS2020 Earnings Calendar: When Do Top Companies Report This Quarter?By Steve FiorilloFeb 13, 2020 9:50 AM EST
PRESS RELEASESAbbVie To Present At The SVB Leerink 9th Annual Global Healthcare ConferenceBy PR NewswireFeb 11, 2020 8:00 AM EST
MARKETSNasdaq, S&P 500 Close at Record Highs as Wall Street Assesses Jump in Coronavirus DeathsBy Joseph WoelfelFeb 10, 2020 2:28 PM EST
INVESTINGAllergan Tops Q4 Earnings Forecast, Sees $63 Billion AbbVie Deal Closing in Q1By Martin BaccardaxFeb 10, 2020 9:31 AM EST
LATEST NEWSUpdates on Wuhan Coronavirus: Over 40,000 Infected, Death Toll Tops 900By Adam SmithFeb 9, 2020 6:44 PM EST
MARKETSStocks Close Lower After Jobs Report and as Coronavirus Worries LingerBy Joseph WoelfelFeb 7, 2020 2:52 PM EST
INVESTINGAbbVie Tops Q4 Profit Forecast, Sees Solid 2020 as New Drugs Boost SalesBy Martin BaccardaxFeb 7, 2020 10:20 AM EST
MARKETSJobs Report, Credit Suisse, Uber, Activision and 'Friends' - 5 Things You Must Know FridayBy Joseph WoelfelFeb 7, 2020 7:30 AM EST
INVESTINGAbbVie Gains Pre-Earnings on Analyst Nod, Coronavirus Drug DemandBy M. Corey GoldmanFeb 6, 2020 10:54 AM EST
INVESTINGGilead Falls Post-Earnings but China Wants to Patent Its Coronavirus DrugBy M. Corey GoldmanFeb 5, 2020 9:40 AM EST
JIM CRAMERRally With Caution: Cramer's 'Mad Money' Recap (Tuesday 2/4/20)By Scott RuttFeb 5, 2020 12:12 AM EST
JIM CRAMEREarnings Aren't Enough: Cramer's 'Mad Money' Recap (Friday 1/31/20)By Scott RuttFeb 1, 2020 12:03 AM EST
JIM CRAMERWhere's the Bear?: Cramer's 'Mad Money' Recap (Thursdsay 1/30/20)By Scott RuttJan 30, 2020 8:56 PM EST
PRESS RELEASESAlector Announces Initiation Of Phase 1b Study Of AL003 In Alzheimer's Disease PatientsBy GlobeNewswireJan 28, 2020 8:30 AM EST
JIM CRAMERViral Risk: Cramer's 'Mad Money' Recap (Monday 1/27/20)By Scott RuttJan 27, 2020 8:41 PM EST
INVESTINGTrading AbbVie as Its Drug Is Seen as Possible Coronavirus TreatmentBy Bret KenwellJan 27, 2020 12:55 PM EST
VideoJim Cramer Weighs In on Kobe Bryant's Legacy, Stock Picks Amidst Coronavirus FearsJan 27, 2020 11:18 AM EST
HEALTHAbbVie HIV Drugs Being Tested as Possible Coronavirus AntidoteBy M. Corey GoldmanJan 27, 2020 11:44 AM EST
MERGERS AND ACQUISITIONSAllergan Sells Drugs to Nestle and AstraZeneca Ahead of AbbVie Tie-UpBy M. Corey GoldmanJan 27, 2020 10:04 AM EST
